skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

5 Total results for product and free and sample content found

In Vivo, Medtech Insight

Transforming Cancer Treatment with Early Detection Diagnostics: Opportunities And Obstacles Webinar

Early Diagnostic webinar slides

Join distinguished cancer and industry experts as they explore what a shift in cancer treatment – from late stage intervention to an early detection paradigm – would mean for patient outcomes, cancer costs, technology, development, regulatory affairs, and more. Explore this new approach toward focusing on early stage cancer detection, including discussion of diagnostics in this area, such as biomarker identification, liquid biopsies, and monitoring technologies.

Topic Diagnostics Cancer

Medtech Insight

Cognoa Seeks De Novo Clearance For AI-Powered Diagnostic App For Autism After Successful Study

Autism Study Digital Health

FDA clearance of the ASD Diagnostic app could lead to early diagnosis, improving quality of life of children with ASD and their caregivers.

Topic Diagnostics Digital Health FDA

Medtech Insight

Qiagen Ready To Rival Abbott With Rapid Portable Antigen COVID-19 Test

Qiagen Coronavirus

The diagnostics company said the test is scheduled for US launch in Q4 2020.

Topic Coronavirus Diagnostics In Vitro Diagnostics

Medtech Insight

FDA Boosts Development Of OTC COVID-19 Tests With New Template

FDA Boosts Development Of OTC COVID-19 Tests With New Template

A new template from the US FDA explains what information the agency wants to see in regulating COVID-19 tests to be performed outside the laboratory environment.

Topic Coronavirus FDA Diagnostics

Medtech Insight

FDA Clears CDC Diagnostic For COVID-19 And Influenza

mti-FDA-Clears-CDC

The US FDA has authorized marketing of a combination diagnostic that can detect either COVID-19 or influenza. The agency hopes to encourage development of additional similar tests before the fall flu season.

Topic Coronavirus Diagnostics In Vitro Diagnostics Regulation

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: